RESUMO
BACKGROUND: Human papillomavirus (HPV) has been implicated in the development of digital squamous cell carcinoma (SCC). Case reports in the literature mostly identify HPV type 16 present in tumors, but HPV types 2, 31, 34, 35, and 73 have also been isolated. METHODS: Two cases of digital SCC associated with HPV 16 in young African-American men are presented. RESULTS AND CONCLUSIONS: Digital SCC associated with HPV may be difficult to evaluate and treat, particularly in African-Americans and patients with human immunodeficiency virus (HIV). We discuss the need for careful evaluation, treatment, and follow-up of these individuals.
Assuntos
Carcinoma de Células Escamosas/virologia , Papillomavirus Humano 16 , Doenças da Unha/virologia , Infecções por Papillomavirus/complicações , Neoplasias Cutâneas/virologia , Infecções Oportunistas Relacionadas com a AIDS/complicações , Adulto , Negro ou Afro-Americano , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/cirurgia , Humanos , Masculino , Doenças da Unha/patologia , Doenças da Unha/cirurgia , Infecções por Papillomavirus/patologia , Infecções por Papillomavirus/cirurgia , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/cirurgiaRESUMO
In situations where acne has proved resistant to other systemic agents or they are not indicated and isotretinoin is not desired by patients, the authors find amoxicillin, TMP-SMX, and spironolactone, alone or in combination, useful alternatives. In women who have acne, spironolactone can be used, and in patients who have sulfa allergy, amoxicillin can be used. It is important to continue alternate topical therapy along with these interventions to augment the improvement and to assist in the eventual discontinuance of oral medication. All of the authors' patients were using topical therapy concomitantly and, although this may have contributed to improvement, the authors believe the addition of amoxicillin, TMP-SMX, or spironolactone contributes to the majority of improvement. Tetrospective chart analysis provides supportive data for amoxicillin, TMP-SMX, and spironolactone in the treatment of refractory acne vulgaris.